Pfizer (PFE +0.7%) gets a lift today after saying it's made available its Quillivant XR, for the...


Pfizer (PFE +0.7%) gets a lift today after saying it's made available its Quillivant XR, for the treatment of attention deficit hyperactivity disorder, in the U.S. Quillivant XR was approved by the FDA in September, 2012.

From other sites
Comments (1)
  • Special_Sit
    , contributor
    Comments (166) | Send Message
     
    Was the move really due to launch of an oral suspension of generic ritalin? Or simply technical momentum. The latter would be my guess.
    14 Jan 2013, 09:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs